Nationwide Fund Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-124,351
| Closed | -$7.62M | – | 1337 |
|
|
2017
Q3 | $7.62M | Buy |
124,351
+3,800
| +3% | +$233K | 0.03% | 817 |
|
|
2017
Q2 | $5.55M | Sell |
120,551
-6,080
| -5% | -$280K | 0.02% | 955 |
|
|
2017
Q1 | $5.48M | Buy |
126,631
+21,922
| +21% | +$949K | 0.02% | 944 |
|
|
2016
Q4 | $4.05M | Buy |
104,709
+53,960
| +106% | +$2.09M | 0.02% | 1100 |
|
|
2016
Q3 | $2.57M | Buy |
50,749
+4,691
| +10% | +$238K | 0.01% | 1273 |
|
|
2016
Q2 | $2.09M | Sell |
46,058
-47,098
| -51% | -$2.14M | 0.01% | 1335 |
|
|
2016
Q1 | $3.82M | Buy |
93,156
+1,272
| +1% | +$52.2K | 0.02% | 1072 |
|
|
2015
Q4 | $5.2M | Buy |
91,884
+18,304
| +25% | +$1.04M | 0.02% | 895 |
|
|
2015
Q3 | $2.93M | Sell |
73,580
-7,345
| -9% | -$292K | 0.01% | 1179 |
|
|
2015
Q2 | $3.87M | Buy |
80,925
+3,653
| +5% | +$174K | 0.02% | 1100 |
|
|
2015
Q1 | $3.07M | Buy |
77,272
+19,682
| +34% | +$781K | 0.01% | 1238 |
|
|
2014
Q4 | $1.29M | Sell |
57,590
-705
| -1% | -$15.8K | 0.01% | 1675 |
|
|
2014
Q3 | $913K | Sell |
58,295
-205
| -0.4% | -$3.21K | ﹤0.01% | 1867 |
|
|
2014
Q2 | $868K | Buy |
58,500
+4,375
| +8% | +$64.9K | ﹤0.01% | 1946 |
|
|
2014
Q1 | $871K | Buy |
54,125
+2,606
| +5% | +$41.9K | ﹤0.01% | 1798 |
|
|
2013
Q4 | $481K | Sell |
51,519
-1,588
| -3% | -$14.8K | ﹤0.01% | 2264 |
|
|
2013
Q3 | $601K | Buy |
53,107
+2,503
| +5% | +$28.3K | ﹤0.01% | 2126 |
|
|
2013
Q2 | $677K | Buy |
+50,604
| New | +$677K | ﹤0.01% | 1868 |
|